Skip to main content
Top
Published in: Journal of Cancer Survivorship 5/2018

01-10-2018

Reproductive and gynecological complication risks among thyroid cancer survivors

Authors: Brenna E. Blackburn, Patricia A. Ganz, Kerry Rowe, John Snyder, Yuan Wan, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken Smith, Kimberley Herget, Jaewhan Kim, Anne C. Kirchhoff, Christina Porucznik, Heidi Hanson, Dev Abraham, Marcus Monroe, Mia Hashibe

Published in: Journal of Cancer Survivorship | Issue 5/2018

Login to get access

Abstract

Purpose

Thyroid cancer is the most rapidly increasing cancer in the USA, affects a young, mostly female population, and has high survival. The aim of this study was to determine if there is an increased risk of reproductive system adverse events or pregnancy complications among women diagnosed with thyroid cancer under the age of 50.

Methods

Up to five female cancer-free individuals were matched to each female thyroid cancer survivor diagnosed before the age of 50 based on birth year, birth state, and follow-up time, within the Utah Population Database. Medical records were used to identify disease diagnoses stratified over three time periods: 0–1, > 1–5, and > 5–10 years after cancer diagnosis. Cox proportional hazards models were used to estimate hazard ratios (HR) with adjustment on matching factors, race, BMI, and Charlson Comorbidity Index.

Results

There were 1832 thyroid cancer survivors and 7921 matched individuals. Thyroid cancer survivors had higher rates of having multiple health conditions associated with the gynecological system (15.4% vs. 9.4%) and pregnancy (14.3% vs 9.5%) > 1–5 years after cancer diagnosis. Increased risks persisted > 5–10 years after cancer diagnosis for menopausal disorders (HR = 1.78, 99% CI = 1.37, 2.33) and complications related to pregnancy (HR = 2.13, 99% CI = 1.14, 3.98). Stratified analyses showed these risks remained increased across different treatment types.

Conclusions

There were significant risk increases in reproductive system and pregnancy complications among female thyroid cancer survivors within this study.

Implications for Cancer Survivors

Although radiation has been linked to reproductive risks in previous studies, we found risks were increased in patients regardless of treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Society AC. Cancer treatment & survivorship facts & figures 2016–2017. Atlanta: American Cancer Society; 2016. Society AC. Cancer treatment & survivorship facts & figures 2016–2017. Atlanta: American Cancer Society; 2016.
8.
go back to reference Banach R, Bartes B, Farnell K, Rimmele H, Shey J, Singer S, et al. Results of the thyroid cancer alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens). 2013;12(3):428–38.CrossRef Banach R, Bartes B, Farnell K, Rimmele H, Shey J, Singer S, et al. Results of the thyroid cancer alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens). 2013;12(3):428–38.CrossRef
11.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
18.
go back to reference Fard-Esfahani A, Hadifar M, Fallahi B, Beiki D, Eftekhari M, Saghari M, et al. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma. Hell J Nucl Med. 2009;12(1):37–40.PubMed Fard-Esfahani A, Hadifar M, Fallahi B, Beiki D, Eftekhari M, Saghari M, et al. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma. Hell J Nucl Med. 2009;12(1):37–40.PubMed
21.
go back to reference Hadley EE, Discacciati A, Costantine MM, Munn MB, Pacheco LD, Saade GR, et al. Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2017:1–8. https://doi.org/10.1080/14767058.2017.1378329. Hadley EE, Discacciati A, Costantine MM, Munn MB, Pacheco LD, Saade GR, et al. Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2017:1–8. https://​doi.​org/​10.​1080/​14767058.​2017.​1378329.
Metadata
Title
Reproductive and gynecological complication risks among thyroid cancer survivors
Authors
Brenna E. Blackburn
Patricia A. Ganz
Kerry Rowe
John Snyder
Yuan Wan
Vikrant Deshmukh
Michael Newman
Alison Fraser
Ken Smith
Kimberley Herget
Jaewhan Kim
Anne C. Kirchhoff
Christina Porucznik
Heidi Hanson
Dev Abraham
Marcus Monroe
Mia Hashibe
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0707-7

Other articles of this Issue 5/2018

Journal of Cancer Survivorship 5/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine